on of the Dynamitron line of 
business in the US. This was a non-major 
business for IBA and Management decided to re-
focus the efforts on developing its other 
sterilization devices. For the year-ended on December 31, 2023, the 
financial result (expenses) was EUR -5.2million 
(2022: EUR -5.4 million expenses). In 2023, despite decreasing interests payments and 
improved foreign currency impacts (realised and 
un-realised gains and losses as well as change 
in fair value of derivatives), the group was 
strongly impacted by the effects of hyperinflation 
in Argentina.